Fruiting Body vs. Mycelium

Understanding the critical quality distinction between fruiting body extracts and grain-grown mycelium products — what the research says and how to evaluate supplements.

The Most Important Quality Question

The single most important factor in choosing a medicinal mushroom supplement is understanding what part of the organism the product is made from. This distinction significantly affects the bioactive compound profile, beta-glucan content, and clinical relevance.

Mushroom Biology Basics

A mushroom organism has two main growth stages:

Mycelium

  • The vegetative body — a network of thread-like cells (hyphae) that grows through a substrate
  • Analogous to the root system of a plant
  • In nature, grows through soil, wood, or other organic matter
  • In supplement production, typically grown on grain (rice, oats, sorghum)

Fruiting Body

  • The reproductive structure — what we commonly recognize as a “mushroom”
  • Produced when environmental conditions trigger fruiting
  • Contains the highest concentration of many bioactive compounds
  • Historically, the part used in traditional medicine for thousands of years

The Mycelium-on-Grain (MOG) Problem

Most mycelium-based supplements in the US market are produced using a process called solid-state fermentation on grain:

  1. Sterilized grain (typically rice or oats) is inoculated with mushroom mycelium
  2. Mycelium grows through the grain over 30-60 days
  3. The entire substrate — mycelium plus residual grain — is dried and powdered
  4. This is sold as a “mushroom” supplement

The Issue

The mycelium cannot be physically separated from the grain substrate. The resulting product is a mixture of:

  • Mushroom mycelium (variable %)
  • Residual grain starch (often 50-70% of the product)
  • Some mycelium-specific metabolites

This means a significant portion of each capsule is grain starch rather than mushroom material.

How to Identify MOG Products

  • Label says “mycelium” or “mycelial biomass” rather than “fruiting body”
  • Lists grain in ingredients (e.g., “myceliated brown rice”)
  • Reports “polysaccharide” content rather than “beta-glucan” content
  • High alpha-glucan content on third-party testing
  • Often produced in the USA (most US mushroom supplements use this method)

Comparing Compound Profiles

Compound ClassFruiting BodyMycelium on Grain
Beta-glucans25-50%5-15% (diluted by grain)
Alpha-glucans (starch)1-5%30-60%
Triterpenes (Reishi)HighLow to moderate
Hericenones (Lion’s Mane)PresentAbsent
Erinacines (Lion’s Mane)AbsentPresent
Cordycepin (Cordyceps)High (C. militaris FB)Variable
ErgosterolHighLower

The Exception: Lion’s Mane

Lion’s Mane (Hericium erinaceus) is the one case where mycelium has a legitimate advantage:

  • Erinacines (potent NGF-stimulating compounds) are found only in the mycelium
  • Hericenones (also NGF-stimulating) are found only in the fruiting body
  • Both compound classes have demonstrated neurotropic activity
  • A combination product (or taking both forms) may offer the most complete benefit

For most other species, fruiting body extracts are clearly superior in bioactive compound content.

Quality Benchmarks

What to Look For

  • “Fruiting body” or “fruiting body extract” on the label
  • Beta-glucan content >25% (verified by Megazyme assay)
  • Hot water or dual extraction specified
  • Species identified by Latin name
  • Third-party tested (USP, ConsumerLab, NSF)

Red Flags

  • “Mycelium” or “full spectrum” without specifying fruiting body
  • Only reporting “polysaccharides” (includes grain starch)
  • “Myceliated grain” or grain listed in other ingredients
  • No beta-glucan percentage specified
  • Extremely low price per serving (may indicate grain filler)

Traditional Use Context

For thousands of years in Traditional Chinese Medicine, Japanese Kampo, and Korean traditional medicine, the fruiting body was exclusively used. Mycelium-on-grain products are a modern manufacturing innovation (post-1980s) driven by cost efficiency rather than clinical evidence.

The vast majority of clinical trials on medicinal mushrooms have used either:

  • Fruiting body extracts
  • Purified compounds (PSK, lentinan, D-fraction) derived from fruiting bodies
  • Liquid-fermented mycelium (different from grain-grown MOG)

Sources

  • Chilton (2015) “Redefining Medicinal Mushrooms” Nammex White Paper
  • McCleary & Draga (2016) “Measurement of Beta-Glucan in Mushrooms and Mycelial Products” J AOAC Int
  • Wu et al. (2004) “Differences in bioactive components between cultured mycelia and fruiting bodies of Ganoderma lucidum”
  • Stamets & Chilton (1983) “The Mushroom Cultivator” — foundational text on mushroom biology
  • Real Mushrooms (2019) “Mushroom Beta-Glucans: Fruiting Body vs. Mycelium on Grain” Technical Report
esc
↑↓ navigate open esc close